PIPAC in Gastric Peritoneal Metastasis

NCT07517419 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Peritoneal Metastases

Interventions

DRUG: Cisplatin and Doxorubicin

Sponsor

Chinese University of Hong Kong